Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl C Peck

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Clinical Pharmacology and Therapeutics|October 28, 2020
Farewell to our Wonderful Friend and Colleague, J. Richard (Dick) Crout (1929-2020)Robert J Temple, Robert T O'Neill, Carl C Peck
Clinical Pharmacology and Therapeutics|September 11, 2003
Randomized concentration-controlled trials: motivations, use, and limitationsHolger Kraiczi, Theo Jang, Thomas Ludden, et al.
British Journal of Clinical Pharmacology|July 11, 2019
Report on the current status of the use of real-world data (RWD) and real-world evidence (RWE) in drug development and regulationAlasdair M Breckenridge, Ross A Breckenridge, Carl C Peck
The AAPS Journal|December 16, 2005
Evidence of effectiveness: how much can we extrapolate from existing studies?Howard Lee, Dong-Seok Yim, Honghui Zhou, et al.
Physiological Reports|March 1, 2018
Individualized treatment strategies for hyperuricemia informed by a semi-mechanistic exposure-response model of uric acid dynamicsSergey Aksenov, Carl C Peck, Ulf G Eriksson, et al.
Drug Design, Development and Therapy|December 21, 2016
Determination of the starting dose in the first-in-human clinical trials with monoclonal antibodies: a systematic review of papers published between 1990 and 2013Hoon Young Suh, Carl C Peck, Kyung-Sang Yu, et al.
Clinical Pharmacology and Therapeutics|April 24, 2003
Population pharmacokinetic and pharmacodynamic modeling of etanercept using logistic regression analysisHoward Lee, Hui C Kimko, Mark Rogge, et al.
Journal of Clinical Pharmacology|February 11, 2005
Population pharmacokinetic analysis and simulation of the time-concentration profile of etanercept in pediatric patients with juvenile rheumatoid arthritisDong-Seok Yim, Honghui Zhou, Mary Buckwalter, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 21, 2006
Simulation of correlated continuous and categorical variables using a single multivariate distributionStacey J Tannenbaum, Nicholas H G Holford, Howard Lee, et al.
Nature Reviews. Drug Discovery|February 4, 2017
Poor medication adherence in clinical trials: consequences and solutionsAlasdair Breckenridge, Jeffrey K Aronson, Terrence F Blaschke, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Clinical Pharmacology and Therapeutics|October 28, 2020
Farewell to our Wonderful Friend and Colleague, J. Richard (Dick) Crout (1929-2020)Robert J Temple, Robert T O'Neill, Carl C Peck
Clinical Pharmacology and Therapeutics|September 11, 2003
Randomized concentration-controlled trials: motivations, use, and limitationsHolger Kraiczi, Theo Jang, Thomas Ludden, et al.
British Journal of Clinical Pharmacology|July 11, 2019
Report on the current status of the use of real-world data (RWD) and real-world evidence (RWE) in drug development and regulationAlasdair M Breckenridge, Ross A Breckenridge, Carl C Peck
The AAPS Journal|December 16, 2005
Evidence of effectiveness: how much can we extrapolate from existing studies?Howard Lee, Dong-Seok Yim, Honghui Zhou, et al.
Physiological Reports|March 1, 2018
Individualized treatment strategies for hyperuricemia informed by a semi-mechanistic exposure-response model of uric acid dynamicsSergey Aksenov, Carl C Peck, Ulf G Eriksson, et al.
Drug Design, Development and Therapy|December 21, 2016
Determination of the starting dose in the first-in-human clinical trials with monoclonal antibodies: a systematic review of papers published between 1990 and 2013Hoon Young Suh, Carl C Peck, Kyung-Sang Yu, et al.
Clinical Pharmacology and Therapeutics|April 24, 2003
Population pharmacokinetic and pharmacodynamic modeling of etanercept using logistic regression analysisHoward Lee, Hui C Kimko, Mark Rogge, et al.
Journal of Clinical Pharmacology|February 11, 2005
Population pharmacokinetic analysis and simulation of the time-concentration profile of etanercept in pediatric patients with juvenile rheumatoid arthritisDong-Seok Yim, Honghui Zhou, Mary Buckwalter, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 21, 2006
Simulation of correlated continuous and categorical variables using a single multivariate distributionStacey J Tannenbaum, Nicholas H G Holford, Howard Lee, et al.
Nature Reviews. Drug Discovery|February 4, 2017
Poor medication adherence in clinical trials: consequences and solutionsAlasdair Breckenridge, Jeffrey K Aronson, Terrence F Blaschke, et al.
Pageof 3